• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Public Health England Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England - Updated Release December 2

gsgs

Registered User
UK coronavirus variant found in Malaysia and Singapore
---------------------------------------------------------
Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England
https://cmmid.github.io/topics/covid...l-variant.html
56% more transmissible
found no evidence for greater or lesser severity
Our estimates suggest that control measures of a similar stringency to the national lockdown
implemented in England in November 2020 are unlikely to reduce the effective reproduction
number Rt to less than 1, unless primary schools, secondary schools, and universities are also closed.
-----------------------------------------------

Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England

Status: report | First online: 23-12-2020 | Last update: 23-12-2020

Authors: Nicholas Davies*, Rosanna C Barnard[SUP]1[/SUP], Christopher I Jarvis[SUP]1[/SUP], Adam J Kucharski[SUP]1[/SUP], James D Munday[SUP]1[/SUP], Carl A.B. Pearson[SUP]1[/SUP], Timothy W Russell[SUP]1[/SUP], Damien C Tully[SUP]1[/SUP], Sam Abbott, Amy Gimma, William Waites, Kerry LM Wong, Kevin van Zandvoort, CMMID COVID-19 working group, Rosalind M Eggo, Sebastian Funk, Mark Jit, Katherine E Atkins & W John Edmunds.* corresponding author1 contributed equally

This study has not yet been peer reviewed.

A novel SARS-CoV-2 variant, VOC 202012/01, emerged in southeast England in November 2020 and appears to be rapidly spreading towards fixation. We fitted a two-strain mathematical model of SARS-CoV-2 transmission to observed COVID-19 hospital admissions, hospital and ICU bed occupancy, and deaths; SARS-CoV-2 PCR prevalence and seroprevalence; and the relative frequency of VOC 202012/01 in the three most heavily affected NHS England regions (South East, East of England, and London). We estimate that VOC 202012/01 is 56% more transmissible (95% credible interval across three regions 50-74%) than preexisting variants of SARS-CoV-2. We were unable to find clear evidence that VOC 202012/01 results in greater or lesser severity of disease than preexisting variants. Nevertheless, the increase in transmissibility is likely to lead to a large increase in incidence, with COVID-19 hospitalisations and deaths projected to reach higher levels in 2021 than were observed in 2020, even if regional tiered restrictions implemented before 19 December are maintained. Our estimates suggest that control measures of a similar stringency to the national lockdown implemented in England in November 2020 are unlikely to reduce the effective reproduction number Rt to less than 1, unless primary schools, secondary schools, and universities are also closed. We project that large resurgences of the virus are likely to occur following easing of control measures. It may be necessary to greatly accelerate vaccine roll-out to have an appreciable impact in suppressing the resulting disease burden.

https://cmmid.github.io/topics/covid19/uk-novel-variant.html
 
Last edited by a moderator:
Source: https://www.theguardian.com/world/2...d-to-higher-viral-load-in-respiratory-samples

New Covid variant linked to higher viral load in respiratory samples
Preliminary analysis suggests higher load makes B117 variant easier to spread to other people
Natalie Grover
Wed 30 Dec 2020 06.00 GMT
Last modified on Wed 30 Dec 2020 11.34 GMT


The hypothesis that the fast-spreading UK variant of the Covid-19 virus has a transmission advantage has been bolstered by an analysis that suggests it is linked to higher loads of the virus in respiratory samples.

The variant, named B117, was discovered during an investigation into why coronavirus cases in Kent continued to rise during the November lockdown. Scientists found it continued to spread during the restrictions while older variants declined.


Some of the lighthouse laboratories created in April to boost Covid-19 testing capacity in places such as London and Manchester were beginning to see evidence of the new variant in respiratory samples when the Covid-19 Genomics UK consortium sounded the alarm about B117 and its transmission advantage.

Dr Michael Kidd, of the PHE Public Health Laboratory in Birmingham, and his team analysed a total of 641 samples based on tests from symptomatic patients and found evidence of B117 among other variants. About 35% of patients infected by B117 had high levels of the virus in their samples, compared with 10% of patients without the variant, they said in their still-to-be-peer reviewed study...
 
Back
Top Bottom